ACE I/D基因多态性、血浆ACE水平与1型糖尿病长期肾脏结局及全因死亡
该研究纳入法国和比利时三个队列共1155例长期1型糖尿病患者,中位随访14年,评估ACE I/D多态性对长期肾脏结局及全因死亡的影响。结果显示XD基因型携带者主要肾脏复合终点风险显著高于II型(调整HR 2.07,95%CI 1.32-3.40,P=0.001),且基线血浆ACE水平升高与主要终点风险增加相关。ACE基因型可改善主要终点的风险分层。
要点
- XD基因型与主要肾脏复合终点风险增加独立相关(调整HR 2.07)。
- XD携带者基线血浆ACE水平更高,且与主要终点风险增加相关。
- ACE基因型可改善主要终点的风险分层(NRI 0.154,IDI 0.012)。
核心结论
- ACE I/D多态性的D等位基因与长期1型糖尿病患者主要肾脏事件及全因死亡风险增加相关。
研究设计与样本
- 来自法国和比利时三个队列的1155例长期1型糖尿病患者,中位随访14年(四分位距13年)。
主要发现
- 主要终点(ESKD或eGFR下降40%)在XD携带者中发生率为20%,II携带者为13%,调整HR 2.07(95%CI 1.32-3.40;P=0.001)。
- XD携带者基线血浆ACE水平更高,且与主要终点风险增加显著相关。
- ACE基因型对主要终点分层的净重分类改善为0.154(95%CI 0.007-0.279;P=0.04),综合判别改善为0.012(95%CI 0.001-0.021;P=0.02)。
临床怎么用
- 在长期1型糖尿病患者中,ACE I/D基因型及基线血浆ACE水平可能有助于识别主要肾脏事件和全因死亡高风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The deletion (D) allele of the ACE insertion/deletion (I/D) polymorphism is a risk factor for diabetic kidney disease. We assessed its contribution to long-term kidney outcomes and all-cause death in patients with long-standing type 1 diabetes. RESEARCH DESIGN AND METHODS: A total of 1,155 participants from three French and Belgian cohorts were monitored for a median duration of 14 (interquartile range 13) years. The primary outcome was the occurrence of end-stage kidney disease (ESKD) or a 40% drop in the estimated glomerular filtration rate (eGFR). Secondary outcomes were the individual components of the primary outcome, rapid decline in eGFR (steeper than -3 mL/min/1.73 m2 per year), incident albuminuria, all-cause death, and a composite ESKD or all-cause death. Hazard ratios (HRs) for XD versus II genotype and for baseline plasma ACE levels were computed by Cox analysis. Genotype performance in stratifying the primary outcome was tested. RESULTS: Genotype distribution was 954 XD and 201 II. The primary outcome occurred in 20% of XD and 13% of II carriers: adjusted HR 2.07 (95% CI 1.32-3.40; P = 0.001). Significant associations were also observed for rapid decline in eGFR, incident albuminuria, ESKD, all-cause death, and ESKD or all-cause death. Baseline plasma ACE levels were higher in XD carriers and significantly associated with an increased risk of the primary outcome. The ACE genotype enhanced net reclassification improvement (0.154, 95% CI 0.007-0.279; P = 0.04) and integrated discrimination improvement (0.012, 95%CI 0.001-0.021; P = 0.02) for primary outcome stratification. CONCLUSIONS: The D-allele of the ACE I/D polymorphism was associated with an increased risk of major kidney events and all-cause death in patients with long-standing type 1 diabetes.
引用
- Abouleka Y, Mohammedi K, Carpentier C, et al. ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes. Diabetes Care. 2021. PMID: 33827803. doi:10.2337/dc20-3036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。